Home World News EMA Recommends Granting a Marketing Authorisation for Ensartinib World News EMA Recommends Granting a Marketing Authorisation for Ensartinib By Ogkologos - October 9, 2026 311 0 Facebook Twitter Google+ Pinterest WhatsApp It is intended for the treatment of adult patients with ALK-positive, advanced NSCLC Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR TP53 Allelic State is Critical in Myelodysplastic Syndromes August 4, 2020 NExT: Advancing Promising Cancer Therapies from the Lab to Clinical Trials June 29, 2018 Lymph Node Biopsies Are Unnecessary For Early-Stage Breast Cancer Patients, Study... January 7, 2020 RANO and Modified RANO Criteria Demonstrate Similar Correlations Between PFS and... April 18, 2023 Load more HOT NEWS Reducing Cancer’s Global Burden: A Conversation with NCI’s Dr. Satish Gopal Qué saber al buscar información sobre el cáncer en línea: perspectiva... Safety and Preliminary Signs of Activity of OMO-103, a MYC Inhibitor,... Talquetamab Continuous To Demonstrate High Overall Response Rates in Heavily Pretreated...
